At a glance
ClinicalIndex Comparison RecordN/ACompleted· 54 enrolled
Drug / intervention
senofilcon A +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
2-week Dispensing Cross-Over Evaluation of Marketed Silicone Hydrogel Contact Lenses in an Indian Population
In Brief
A clinical study evaluating senofilcon A and lotrafilcon B for Visual Acuity. Completed, enrolled 54 participants across 1 site.
Detailed Summary
The primary objective of this study is to evaluate the clinical performance of two marketed silicone hydrogel contact lenses in an Indian population in the following areas: physiological characteristics, comfort characteristics and vision characteristics.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesIndia
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJan 2015
First PostedMar 2015
Primary CompletionSep 2015
TodayJul 2026
First PostedMar 20, 2015
Enrollment StartJan 1, 2015
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 11.3 years ago
Interventions
senofilcon Adevice
One fresh pair of contact lenses worn for 11 (+/-2) days, for a minimum of 6 hours per day
lotrafilcon Bdevice
One fresh pair of contact lenses worn for 11 (+/-2) days, for a minimum of 6 hours per day